1. Increased Time From Neoadjuvant Chemoradiation to Surgery Is Associated With Higher Pathologic Complete Response Rates in Esophageal Cancer 
Talha Shaikh, MD, Karen Ruth, MS, Walter J. Scott, MD, Barbara A. Burtness, MD, Steven J. Cohen, MD, Andre A. Konski, MD, Harry S. Cooper, MD, Igor Astsaturov, MD, Joshua E. Meyer, MD 
The Annals of Thoracic Surgery 
Volume 99, Issue 1, Pages (January 2015)
DOI: /j.athoracsur
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

2. Fig 1
Elapsed time (days) from neoadjuvant chemoradiation treatment (NCRT) to surgery. (n = 88; mean 57.1, median 50.5, minimum 26, maximum 204.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

3. Fig 2
Pathologic response (light blue, residual; medium blue, microfoci; dark blue, pathologic complete response [pCR]) by interval from end of chemoradiation therapy (CRT) to surgery by (A) quartile and (B) 3-week interval group.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions

4. Fig 3
Kaplan-Meier plots for overall survival by interval quartile (Q): I (lime-green), II (green), III (blue), and IV (purple). (Num. = number.)
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur )
Copyright © 2015 The Society of Thoracic Surgeons Terms and Conditions